Posted by SLS on September 18, 2009, at 11:09:48
In reply to Sleep drug - Ciltyri (Eplivanserin) delayed, posted by jrbecker76 on September 17, 2009, at 23:49:42
> FDA cite's problem with the drug's "benefit-risk" profile....
>
> http://www.fool.com/investing/general/2009/09/17/sleepless-in-sanofi.aspx
Is this drug a true hypnotic or does it improve the neurobiology of the underlying disorder by blocking 5-HT2a receptors? If it is not sedating, it might make an interesting augmenter of antidepressants.
- Scott
poster:SLS
thread:917535
URL: http://www.dr-bob.org/babble/20090912/msgs/917567.html